Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years.

Jainaba Njie-Jobe | Samuel Nyamweya | David J C Miles | Marianne van der Sande | Syed Zaman | Ebrima Touray | Safayet Hossin | Jane Adetifa | Melba Palmero | Sarah Burl | David Jeffries | Sarah Rowland-Jones | Katie Flanagan | Assan Jaye | Hilton Whittle
Vaccine | 2012

Measles vaccine in early infancy followed by a dose at 9 months of age protects against measles and enhances child survival through non-specific effects. Little is known of immune responses in the short or long term after booster doses.

Pubmed ID: 22314136

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: Medical Research Council, United Kingdom
    Id: MC_U190074200
  • Agency: Medical Research Council, United Kingdom
    Id: MC_U190088487
  • Agency: Medical Research Council, United Kingdom
    Id: SCC 948

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Vero (tool)

RRID:CVCL_0059

Cell line Vero is a Spontaneously immortalized cell line with a species of origin Chlorocebus sabaeus

View all literature mentions